Regentis Biomaterials Ltd.

Medical Instruments & Supplies • Healthcare • Herzliya, Israel • RGNT (ASE)

Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions in the United States. The company offers orthopedic treatments using Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GelrinC, is a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. It offers Gelrin is a unique hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Regentis Biomaterials Ltd. was incorporated in 2004 and is based in Herzliya, Israel.

972 9 960 1917 60 Medinat Hayehudim Street, Israel

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering - Yahoo Finance

Yahoo Finance • Dec 3

RGNT Stock Price and Chart — AMEX:RGNT - TradingView — Track All Markets

TradingView — Track All Markets • Nov 20

Regentis Biomaterials raises $10 million in NYSE American IPO - Investing.com

Investing.com • Dec 5

Regentis Biomaterials announces pricing of initial public offering for $10M - MSN

MSN • Dec 5

Regentis Biomaterials Prices IPO At $8 Per Share - RTTNews

RTTNews • Dec 4

Other Medical Instruments & Supplies Companies

View All →

Intuitive Surgical Inc.

$206.27B market cap

Becton Dickinson & Co.

WEST Pharmaceutical Services Inc.

$19.83B market cap

Frequently Asked Questions

Has REGENTIS BIOMATERIALS LTD. had layoffs?

No layoff events have been recorded for REGENTIS BIOMATERIALS LTD. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does REGENTIS BIOMATERIALS LTD. have?

REGENTIS BIOMATERIALS LTD. has approximately 3 employees.

What industry is REGENTIS BIOMATERIALS LTD. in?

REGENTIS BIOMATERIALS LTD. operates in the Medical Instruments & Supplies industry, within the Healthcare sector.

Is REGENTIS BIOMATERIALS LTD. a publicly traded company?

Yes, REGENTIS BIOMATERIALS LTD. is publicly traded under the ticker symbol RGNT on the ASE. The company has a market capitalization of approximately $0.03 billion.

Where is REGENTIS BIOMATERIALS LTD. headquartered?

REGENTIS BIOMATERIALS LTD. is headquartered in Herzliya, Israel at 60 Medinat Hayehudim Street, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.